Wockhardt Profit & Loss Annual

Trade
BSE: 532300 | NSE: WOCKPHARMA | ISIN: INE049B01025 | Sector: Biotechnology & Drugs
1,292.45 +61.50 (5.00%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,798.002,651.003,230.002,708.30
Total Revenue 2,798.002,651.003,230.002,708.30
Costof Revenue Total 1,165.001,176.001,354.001,268.66
Gross Profit 1,633.001,475.001,876.001,439.64
Selling/ General/ Admin Expenses Total 629.001,149.001,353.001,251.53
Depreciation/ Amortization 223.00251.00247.00246.02
Unusual Expense( Income) 93.00171.00183.00142.48
Other Operating Expenses Total 834.00225.00225.00248.68
Total Operating Expense 2,944.002,972.003,362.003,157.37
Operating Income -146.00-321.00-132.00-449.07
Interest Inc( Exp) Net- Non- Op Total -3,050.00-2,070.00-2,930.00-2,308.40
Gain( Loss)on Saleof Assets -520.00-940.000.00947.00
Other Net 83.00-2.0014.0016.87
Net Income Before Taxes -420.00-624.00-411.00-568.34
Provisionfor Income Taxes 52.00-3.00-132.00-271.61
Net Income After Taxes -472.00-621.00-279.00-296.73
Minority Interest 9.0062.0035.00-2.54
Net Income Before Extra Items -463.00-559.00-244.00-299.27
Net Income -463.00-559.00-244.00686.06
Income Availableto Com Excl Extra Ord -463.00-559.00-244.00-299.27
Income Availableto Com Incl Extra Ord -463.00-559.00-244.00686.06
Diluted Net Income -463.00-559.00-244.00686.06
Diluted Weighted Average Shares 14.4514.4112.0612.01
Diluted EPS Excluding Extra Ord Items -32.05-38.79-20.24-24.91
Diluted Normalized EPS -25.53-25.35-10.37-22.32
Total Extraordinary Items --0.00985.33
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts